A. Hosokawa

797 total citations
17 papers, 141 citations indexed

About

A. Hosokawa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Hosokawa has authored 17 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in A. Hosokawa's work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Hosokawa is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Hosokawa collaborates with scholars based in Japan, United States and United Kingdom. A. Hosokawa's co-authors include Toshihiko Doi, Atsushi Ohtsu, Liebwin Goßner, Yasuo Endo, Shin’ichi Miyamoto, Koichi Hosokawa, Shigeto Yoshida, Manabu Muto, Daizo Saito and Toshiro Sugiyama and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A. Hosokawa

17 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Hosokawa Japan	6	103	70	69	34	7	17	141
Rajesh Puri India	6	62 0.6×	128 1.8×	62 0.9×	31 0.9×	2 0.3×	32	139
O. Triossi Italy	7	56 0.5×	69 1.0×	58 0.8×	44 1.3×	5 0.7×	19	125
Keijirou Sugimura Japan	11	212 2.1×	227 3.2×	54 0.8×	41 1.2×	6 0.9×	21	265
Ryusuke Aihara Japan	6	281 2.7×	128 1.8×	203 2.9×	32 0.9×	3 0.4×	14	325
Armin Kuellmer Germany	7	134 1.3×	91 1.3×	76 1.1×	77 2.3×		14	181
Nicolas Tinton Belgium	6	78 0.8×	135 1.9×	20 0.3×	50 1.5×	9 1.3×	10	169
Zhenjuan Li China	10	129 1.3×	161 2.3×	133 1.9×	12 0.4×	5 0.7×	24	221
John N. Groen Netherlands	6	107 1.0×	65 0.9×	52 0.8×	98 2.9×		7	162
Joaquin J Gama-Rodrigues United Kingdom	4	204 2.0×	108 1.5×	105 1.5×	30 0.9×		5	222

Countries citing papers authored by A. Hosokawa

Since Specialization

Citations

This map shows the geographic impact of A. Hosokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hosokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hosokawa more than expected).

Fields of papers citing papers by A. Hosokawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hosokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hosokawa. The network helps show where A. Hosokawa may publish in the future.

Co-authorship network of co-authors of A. Hosokawa

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hosokawa. A scholar is included among the top collaborators of A. Hosokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hosokawa. A. Hosokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Arkenau, Hendrik‐Tobias, Josep Tabernero, Kohei Shitara, et al.. (2018). TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer. Annals of Oncology. 29. viii718–viii718. 1 indexed citations

Okuyama, Hiroyuki, Masafumi Ikeda, Takuji Okusaka, et al.. (2018). A phase II study of everolimus in patients with unresectable pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy. Annals of Oncology. 29. viii469–viii470. 1 indexed citations

Yuki, Satoshi, Yoshito Komatsu, Yasushi Tsuji, et al.. (2017). A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer [HGCSG1503]: Updated analysis. Annals of Oncology. 28. v204–v205. 1 indexed citations

Ioka, Tatsuya, Akira Fukutomi, Junki Mizusawa, et al.. (2016). Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (LAPC): Final analysis of JCOG1106. Annals of Oncology. 27. vi211–vi211. 4 indexed citations

Yuki, Satoshi, Yoshimichi Komatsu, Toshiya Muranaka, et al.. (2016). Phase II trial of panitumumab monotherapy for patients with KRAS exon2 wild type colorectal cancer after progression on cetuximab. HGCSG1101. Annals of Oncology. 27. vi164–vi164. 2 indexed citations

Kakushima, Naomi, Hiroyuki Ono, Takahiro Horimatsu, et al.. (2015). Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial. Journal of Gastroenterology. 51(2). 104–111. 9 indexed citations

Ando, Takayuki, A. Hosokawa, Sohachi Nanjo, et al.. (2014). Molecular Characterization of Gastric Neuroendocrine Carcinoma Based on Extensive Sequence Variation and Genome-Wide Methylation Analysis. Annals of Oncology. 25. iv568–iv568. 1 indexed citations

Shitara, Kohei, Satoshi Yuki, Michio Nakamura, et al.. (2013). Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer. British Journal of Cancer. 110(2). 271–277. 23 indexed citations

Hosokawa, A., K. Ogawa, Jun Nishikawa, et al.. (2013). Endoscopic submucosal dissection for superficial esophageal neoplasms using the stag beetle knife. Diseases of the Esophagus. 27(1). 50–54. 23 indexed citations

10.

Kasuga, Akiyoshi, Toshio Yamaguchi, Nozomu Machida, et al.. (2012). Multicenter Retrospective Analysis of Systemic Chemotherapy for Advanced Poorly Differentiated Neuroendocrine Carcinoma of Digestive System. Annals of Oncology. 23. xi123–xi124. 1 indexed citations

11.

Komatsu, Y., et al.. (2011). Retrospective Cohort Study on the Safety and Efficacy of Bevacizumab with Chemotherapy for Metastatic Colorectal Cancer Patients: The HGCSG0801 Study. Japanese Journal of Clinical Oncology. 41(4). 490–497. 7 indexed citations

12.

Hosokawa, A., Shinya Kajiura, Yuka Kobayashi, et al.. (2009). 3508 Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study. European Journal of Cancer Supplements. 7(2). 204–204. 1 indexed citations

13.

Miyazaki, Tatsuya, et al.. (2008). The modified glucose clearance test: a novel non‐invasive method for differentiating non‐erosive reflux disease and erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 28(10). 1259–1264. 8 indexed citations

14.

Muto, Manabu, Shin’ichi Miyamoto, A. Hosokawa, et al.. (2005). Endoscopic Mucosal Resection in the Stomach Using the Insulated-Tip Needle-Knife. Endoscopy. 37(2). 178–182. 53 indexed citations

15.

Hosokawa, A.. (2003). Weekly Hepatic Arterial Infusion of 5-Fluorouracil and Subsequent Systemic Chemotherapy for Liver Metastases from Colorectal Cancer. Japanese Journal of Clinical Oncology. 33(3). 132–135. 4 indexed citations

16.

Yamamoto, Takuaki, Takashi Abe, Kazumichi KOBAYASHI, et al.. (2000). [A case with juvenile rheumatoid arthritis who developed cerebral vasculitis and venovascular hypertension].. PubMed. 40(5). 818–23. 1 indexed citations

17.

Takahashi, Takeo, T Hayashi, A. Hosokawa, et al.. (1998). [Localized pulmonary infiltration in chronic myelomonocytic leukemia].. PubMed. 39(3). 205–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact